Industry-Sponsored Research: Author's Reply
نویسنده
چکیده
Joal Hill I read with interest the debate about for-profi t versus non-profi t institutional review boards (IRBs) [1], but was disappointed that no one addressed the ability (or inability) of for-profi t IRBs to review studies with the local context of research subjects in mind and then monitor what actually occurs during the consent process throughout the research trial. To my mind the “bigness” of for-profi t IRBs may be more of an impediment in protecting research subjects than their inherent confl ict of interest. Our IRB has reviewed consent forms approved by central/for-profi t IRBs that contained obvious errors such as schemas that did not match protocol narrative and use of eight point font in a study of geriatric subjects. Even when the initial review is outstanding, it seems a practical impossibility for a single IRB to provide meaningful monitoring of the actual consent process and implementation of the protocol at sites throughout the country. The greater “effi ciency” of for-profi t IRBs is only a meaningful benefi t if increased speed can be shown not to occur at the expense of careful review of consent forms, real understanding of the local research context, and a commitment to audit the informed consent process throughout the study for the protection of research subjects, including ongoing education and advice for researchers and their teams. This is not to say that all local IRBs perform this function as they should, but it does seem almost impossible for one IRB to perform local review and oversight for research sites around the nation in a way that really makes a difference for the men, women, and children who give of their time and their bodies so that society can benefi t.
منابع مشابه
Journal of Hypertension Reply to "Reflections on Vascular Ageing and Microvascular Pulsatility"
Manuscript Number: JH-D-14-00432 Full Title: Reply to "Reflections on Vascular Ageing and Microvascular Pulsatility" Article Type: Correspondence Corresponding Author: Francesco Stea, M.D. National Research Council, Institute of Clinical Physiology Pisa, ITALY Corresponding Author Secondary Information: Corresponding Author's Institution: National Research Council, Institute of Clinical Physiol...
متن کاملPost market Research of Oral Anti-Diabetic Drugs: Metformin, Glipizide, and Pioglitazone
Article history: Received on: 05/03/2014 Revised on: 14/03/2014 Accepted on: 01/04/2014 Available online: 28/06/2014 The aims of this study were to document the post market research of the pharmaceutical industry and the effects of labeling revisions on post market studies and outcomes of oral anti-diabetics. A literature search identified post market studies of metformin, glipizide, and piogli...
متن کاملDifferential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
BACKGROUND Mapping the international landscape of clinical trials may inform global health research governance, but no large-scale data are available. Industry or non-industry sponsorship may have a major influence in this mapping. We aimed to map the global landscape of industry- and non-industry-sponsored clinical trials and its evolution over time. METHODS We analyzed clinical trials initi...
متن کاملBackground Concern iswidespread aboutpotential sponsorship influence on research, especiallyinpharmacoeconomic
Results Studies sponsoredby selective serotoninreuptake inhibitor (SSRI) manufacturers favoured SSRIs over tricyclic antidepressantsmore thannonindustry-sponsored studies.Studies sponsoredbymanufacturers of newer antidepressants favoured these drugs more than didnon-industry-sponsored studies.Among industry-sponsored studies, modelling studies favoured the sponsor’s drugmore than did administra...
متن کاملMedical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
OBJECTIVES To characterise research relationships between medical specialists and the pharmaceutical industry in Australia. DESIGN AND SETTING Questionnaire survey of medical specialists listed in the Medical Directory of Australia and believed to be in active practice, conducted in 2002 and 2003. MAIN OUTCOME MEASURES Details of medical specialists' involvement in pharmaceutical industry-s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- PLoS Medicine
دوره 3 شماره
صفحات -
تاریخ انتشار 2006